Kayitalire Louis

Chief Medical Officer at Spring Bank Pharmaceuticals, Inc.

Sold, on record
$10k
Dollars the filings state
Form 4 sales
3
Latest Nov 2, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Spring Bank Pharmaceuticals, Inc.Plan not stated
    Jul 2, 2021 2021

    Sold 1,054 shares at $8.43 ($9k)

    Kayitalire Louis, Chief Medical Officer

    Sold 1.9% of holdings ($467k position)54,383 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Spring Bank Pharmaceuticals, Inc.Plan not stated
    Oct 4, 2021 +94 days

    Sold 64 shares at $7.23 ($463)

    Kayitalire Louis, Chief Medical Officer

    Sold 0.1% of holdings ($393k position)54,319 shares leftFiling

  3. 3 Form 4 sale Spring Bank Pharmaceuticals, Inc.Plan not stated
    Nov 2, 2021 +29 days

    Sold 64 shares at $6.83 ($437)

    Kayitalire Louis, Chief Medical Officer

    Sold 0.1% of holdings ($371k position)54,255 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Kayitalire Louis
Source
Nov 2, 2021Nov 4, 2021Spring Bank Pharmaceuticals, Inc.Chief Medical OfficerForm 4 sale64$4370.1%Plan not statedSEC
Oct 4, 2021Oct 6, 2021Spring Bank Pharmaceuticals, Inc.Chief Medical OfficerForm 4 sale64$4630.1%Plan not statedSEC
Jul 2, 2021Jul 7, 2021Spring Bank Pharmaceuticals, Inc.Chief Medical OfficerForm 4 sale1,054$9k1.9%Plan not statedSEC